Moreover, we also examined the p-α-synuclein form as a peculiar protein linked to PD pathophysiology to fully elucidate the neuroprotective impact of the CCR1 blocker BX471 against α-synuclein accumulation. This evidence concerns the gene CCR1 and Parkinson disease.